Dr. Chadi G. Abdallah has expertise in antidepressants clinical trials, translational clinical neuroscience, multimodal neuroimaging, and the development of rapid acting antidepressant for the treatment of depression, PTSD and other stress-related psychiatric disorders. He employs broad range of pharmacological challenges, neuroimaging modalities, and network neuroscience approaches to study the neurobiology of depression and other psychiatric disorders and the mechanisms underlying treatment response and resistance. His research program focuses on understanding the mechanisms underlying trauma, depression, and chronic stress, with emphasis on the role of synaptic connectivity and neuroenergetics.